Your browser doesn't support javascript.
loading
p53, A Victim of the Prion Fashion.
Billant, Olivier; Friocourt, Gaëlle; Roux, Pierre; Voisset, Cécile.
Afiliación
  • Billant O; CRBM, CNRS, UMR5234, 34293 Montpellier, France.
  • Friocourt G; Inserm, Université de Bretagne Occidentale, EFS, UMR 1078, GGB, F-29200 Brest, France.
  • Roux P; CRBM, CNRS, UMR5234, 34293 Montpellier, France.
  • Voisset C; Inserm, Université de Bretagne Occidentale, EFS, UMR 1078, GGB, F-29200 Brest, France.
Cancers (Basel) ; 13(2)2021 Jan 13.
Article en En | MEDLINE | ID: mdl-33450819
ABSTRACT
Identified in the late 1970s as an oncogene, a driving force leading to tumor development, p53 turned out to be a key tumor suppressor gene. Now p53 is considered a master gene regulating the transcription of over 3000 target genes and controlling a remarkable number of cellular functions. The elevated prevalence of p53 mutations in human cancers has led to a recurring questioning about the roles of mutant p53 proteins and their functional consequences. Both mutants and isoforms of p53 have been attributed dominant-negative and gain of function properties among which is the ability to form amyloid aggregates and behave in a prion-like manner. This report challenges the ongoing "prion p53" hypothesis by reviewing evidence of p53 behavior in light of our current knowledge regarding amyloid proteins, prionoids and prions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Francia